Y-Biologics, Inc · (주)와이바이오로직스
Last · KOSDAQ₩10160.00+1760.00 (+20.95%)stale · yahoo · 19617h ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
₩6650.00₩38000.00
Volume—session
| Revenue | ₩2.8B |
|---|---|
| Operating income | ₩-10.9B |
| Net income | ₩-44.5B |
| Free cash flow | ₩-8.0B |
| Operating margin | -390.7% |
| Net margin | -1594.9% |
| Return on equity | -198.3% |
| Period | TTM 2026-03-31 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-03-23
- Operating Cf Burn
- Net Margin Sharply Negative
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -1442.7%
- Accumulated Deficit High — Accumulated deficit / equity 610%
Documents
FormReporting forFiledFlags